Sara Ahmadi

Islamic Azad University, Tehran — IR

Medicine · Health Sciences

22h-index1.9kcitations117works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(72), BRCA gene mutations in cancer(22), Thyroid and Parathyroid Surgery(15), Head and Neck Anomalies(12), Nutrition, Genetics, and Disease(7)

Publications117 total

Post-treatment bacterial self-healing for high-temperature-induced damage in concrete: toward enhanced durability and sustainability
Journal of Sustainable Cement-Based Materials·2025
Thyroid-Stimulating Hormone Suppression Therapy in Thyroid Cancer: Balancing Benefits and Harms
Endocrine Practice·2025
Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2025Open Access
Supplementary Table S2 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2025Open Access
Supplementary Table S3 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2025Open Access
Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors
Surgery·2025
Exploiting network-based drug repositioning to target metastasis in colorectal cancer: In-Silico prediction and in-vitro evidence
Molecular and Cellular Probes·2025Open Access
Development and validation of mRNA expression-based classifiers to predict low-risk thyroid tumors
Frontiers in Endocrinology·2025Open Access
Identifying Risk Factors for Recurrence and Surgical Management for Medullary Thyroid Cancer
Clinical Thyroidology·2024
8172 Retrospective Analysis of mRNA Expression Based Signatures of Thyroid Tumor Invasion and Metastases
Journal of the Endocrine Society·2024Open Access
Supplementary Table S1 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Data from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Supplementary Table S3 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Supplementary Table S2 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Supplementary Table S3 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Supplementary Table S2 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Supplementary Table S1 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Malignant Bethesda III Nodules Behave Differently from Bethesda V/VI Nodules
Clinical Thyroidology·2024
Cost-effectiveness of Molecular Testing for Thyroid Nodules With Indeterminate Cytology
The Journal of Clinical Endocrinology & Metabolism·2024· 2 cited
Outcomes for Low-Risk Papillary Thyroid Carcinoma after Conversion Surgery
Clinical Thyroidology·2024
page 1 of 6Next →

Frequent Co-authors

Erik K. Alexander(11), Ellen Marqusee(10), Iñigo Landa(8), Justine A. Barletta(7), Θεοδώρα Παππά(7), Julie Ann Sosa(6), Athanasios Bikas(6), Xiaoyin “Sara” Jiang(5), Sanziana A. Roman(5), Molly K. Gibson(4), Gautam Dantas(4), Matthew A. Nehs(4), Phillip I. Tarr(3), Barbara Warner(3), Michael T. Stang(3), Nancy L. Cho(3), Gerard M. Doherty(3), Fedaa Najdawi(3), Rachel Jug(3), Kristine Wong(3)